Protease inhibitor therapy in HIV infection

被引：0

作者：

Del Sorbo, F ^{[1
]}

Meraviglia, P ^{[1
]}

Angeli, E ^{[1
]}

Mainini, A ^{[1
]}

Dedivitiis, GF ^{[1
]}

Cargnel, A ^{[1
]}

机构：

[1] Osped L Sacco, Div Malattie Infett 2, Milan, Italy

来源：

AIDS AND RELATED SYNDROMES | 2001年

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：349 / 354

页数：6

共 9 条

[1]

Aber V, 1996, LANCET, V348, P283, DOI 10.1016/S0140-6736(96)05387-1

[2] Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors [J].

Behrens, G ;

Dejam, A ;

Schmidt, H ;

Balks, HJ ;

Brabant, G ;

Körner, T ;

Stoll, M ;

Schmidt, RE .

AIDS, 1999, 13 (10) :F63-F70

[3] Variation in incidence of indinavir-associated nephrolithiasis among HIV-positive patients [J].

Brodie, SB ;

Keller, MJ ;

Ewenstein, BM ;

Sax, PE .

AIDS, 1998, 12 (18) :2433-2437

[4]

Carr A, 2000, AIDS, V14, pS187

[5] A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors [J].

Carr, A ;

Samaras, K ;

Burton, S ;

Law, M ;

Freund, J ;

Chisholm, DJ ;

Cooper, DA .

AIDS, 1998, 12 (07) :F51-F58

[6]

Chesney MA, 1999, AIDS, V13, pS271

[7]

CUNNEY R, 2000, 40 ICAAC TOR SEPT 17, P297

[8]

Mauss S, 2000, AIDS, V14, pS197

[9]

TEBAS P, 2000, 7 C RETR OPP INF SAN

← 1 →